Here, we show that HHT and ATO have a synergic effect to inhibit the proliferation of LSCs, which was identified in KG-1, Kasumi-1, primary CD34+ cells from AML patients, and in an in vivo xenograft model. Here, CD34 is linked to acute myeloid leukemia.